Plain-English translation of NCT05994274 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is looking at heart transplant patients to understand a common problem: abnormal cholesterol and fat levels that develop after transplant surgery. Researchers want to find out whether these fat metabolism changes are linked to organ rejection—a major cause of transplant failure—and to understand the biological mechanisms behind this connection.
After heart transplant, most patients develop abnormal cholesterol and fat levels due to their anti-rejection medications. Over time, these lipid problems can lead to heart disease and transplant failure. However, doctors don't fully understand why this happens or exactly how it affects rejection, so this study aims to fill that gap and improve long-term care for transplant patients.
You likely qualify if…
You likely don't qualify if…
You would be part of a long-term follow-up program at the hospital where you had your transplant. Researchers would regularly collect information about your cholesterol and fat levels through blood tests and track how your body is responding to your transplant over time. The study will also use advanced laboratory techniques to examine how your immune system and lipid metabolism interact, helping doctors better understand rejection risk.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
China